Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 30, Number 9—September 2024
CME ACTIVITY - Research
Clinical Aspects and Disease Severity of Streptococcus dysgalactiae Subspecies equisimilis Bacteremia, Finland1
Viivi Nevanlinna
, Janne Aittoniemi, Reetta Huttunen, Tiina Luukkaala, and Sari Rantala
, Janne Aittoniemi, Reetta Huttunen, Tiina Luukkaala, and Sari Rantala
Table 4
Clinical synopses of 11 patients with Streptococcys dysgalactiae subspecies equisimilis bacteremia who were treated in an intensive care unit during November 2015–November 2019, Finland
| Patient no. | Age, y*/sex | Symptoms | Clinical syndrome | Continuous renal replacement therapy | Mechanical ventilation | Vasopressors | ICU stay, d | Outcome |
|---|---|---|---|---|---|---|---|---|
| 1 |
80/M |
Fever, general deterioration, dyspnea, cough |
Cellulitis, pneumonia |
No |
No |
No |
3 |
Survived |
| 2 |
60/F |
Fever, general deterioration, dyspnea |
Arthritis |
No |
Yes |
No |
3 |
Survived |
| 3 |
71/M |
Fever, pain, general deterioration, altered mental status, dyspnea |
Cellulitis, pneumonia |
No |
No |
Yes |
3 |
Died |
| 4 |
69/F |
Fever, general deterioration, nausea, altered mental status, dyspnea |
Purulent skin infection |
No |
No |
Yes |
4 |
Died |
| 5 |
68/M |
General deterioration, dyspnea |
No defined focus |
No |
No |
Yes |
1 |
Survived |
| 6 |
85/M |
Fever, general deterioration, nausea, dyspnea |
Cellulitis |
No |
No |
Yes |
1 |
Survived |
| 7 |
43/M |
General deterioration |
Cellulitis, spondylitis, arthritis, osteomyelitis |
No |
No |
Yes |
2 |
Survived |
| 8 |
59/M |
Fever, general deterioration, altered mental status |
Cellulitis |
Yes |
No |
No |
4 |
Survived |
| 9 |
82/M |
Fever, pain, general deterioration, altered mental status |
Necrotizing fasciitis |
No |
Yes |
Yes |
2 |
Died |
| 10 |
35/M |
Fever, pain, nausea |
Necrotizing fasciitis, abscess |
No |
No |
Yes |
2 |
Survived |
| 11 | 66/M | Fever, general deterioration, nausea, altered mental status | Pneumonia | No | Yes | Yes | 7 | Survived |
*Age at hospital admission.
1Preliminary results from this study were presented at the European Congress of Clinical Microbiology and Infectious Diseases; April 27–30, 2024; Barcelona, Spain.
Page created: July 02, 2024
Page updated: August 22, 2024
Page reviewed: August 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.